drugset / Trial / NCT00288353
Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes
Phase 3
Terminated
48 enrolled
Northwestern University
National Alliance for Research on Schizophrenia and Depression · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary goal of this study is to examine the triglyceride/high-density lipoprotein (TG/HDL) ratio and the ischemic EKG changes in patients with schizophrenia, schizoaffective disorder or bipolar disorder.
Timeline
- Start
- 2006-01
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aripiprazole | Other / unclassified | — | — |
| Comparator | Ziprasidone | Small molecule | — | — |